Home > Node

Innovation Blossoms

The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products.  It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.

English

Sopharma with a Fascinating Story about Pharmacy at the Career Fair

Interactive Stand and Folk Dances Attracted Children’s Attention

On the 23rd and 24th of November Sopharma took part in the Career Fair, the closing event of the project “I am Proud with the Work of my Parents” of the Bulgarian UN Global Compact Network. The company took part with a mobile laboratory and a presentation intended to keep the attention of both age groups of children – 8-12 years and 12+ years.

English

Treasury shares

Sopharma AD notifies that on December 13, 2018 the Company bought 1 000 own shares representing 0.0007% of the share capital of the Company, at a total value of 3 600.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.60 BGN.

The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from February 23, 2018.

The total number of treasury shares after this transaction is 8 858 836, representing 6.57% of the share capital of the Company.

English

Notification for acquisition of own shares

Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on December 13, 2018 as a result of the distribution of bonus shares to employees on the occasion of the 85th Anniversary of Sopharma AD, the Company transferred to its employees 500 own shares representing 0.0004% of the capital of the Company.

The total number of treasury shares after this transfer is 8 857 836, representing 6.57% of the share capital of the Company.

English

Notification for acquisition of own shares

Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on December 12, 2018 the Company bought 3 000 own shares representing 0.0022% of the share capital of the Company, at a total value of 10 800.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.60 BGN.

The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from February 23, 2018.

The total number of treasury shares after this transaction is 8 858 336, representing 6.57% of the share capital of the Company.

English

Pages